retatrutide weight loss results clinical trial just posted Phase 3 showing up to 30% body over 80 weeks. That is approaching bariatric surgery territory, from a medication., It targets three hormone pathways: retatrutide weight loss clinical trial

doi: 10.1210/clinem/dgaa863 Summary Keywords obesity, insulin-resistance, Tirzepatide, pathophysiology, GIP, GLP - 1, clinical trials, arterial hypertension Citation Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence

Performance, Delivered

Animal models have mapped specific target cell types to downstream restitution programs

It is a hormone, produced in the intestine and important for regulating blood sugar, insulin secretion, appetite, and weight management

Plasma RBP levels can be used to predict vitamin A deficiency